Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Home Access HIV test lacks proper package warnings, Confide inventor contends.

This article was originally published in The Tan Sheet

Executive Summary

HOME ACCESS HIV TEST KIT LACKS MANY OUTSIDE PACKAGE WARNINGS that FDA required of the Confide diagnostic HIV blood test formerly marketed by J&J, Elliot Millenson, the inventor of Confide, contends in a Sept. 8 letter to FDA that follows up on a Feb. 27 citizen petition. With regard to the purported lack of adequate outside warnings on Hoffman Estates, Ill.-based Home Access' blood test for HIV-1, Millenson, of Far Hills, N.J., says there are "no warnings about use by people with clotting disorders, no age use recommendations and no indication the [Home Access] kit is intended for self use."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087547

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel